FDA
approval
· 2021-06-21
FDA Approved: DAPTOMYCIN — Original Application (Hospira, Inc.)
Summary
FDA approved daptomycin (Hospira) under the original application NDA210282, establishing its use for complicated skin and skin structure infections.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DAPTOMYCIN (DAPTOMYCIN)